Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2023, 42, Article number: 145 , pp. 1 - 23 [Scientific article]Open Access
Leoni, Ilaria; Galvani, Giuseppe; Bergamini, Christian; Rizzardi, Nicola; Melli, Mattia; Coada, Camelia Alexandra; Monti, Elisa; Giovannini, Catia; Liparulo, Irene; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib
response in hepatocellular carcinoma, in: Abstract Book - EASL Liver Cancer Summit 2023, 2023(atti di: EASL Liver Cancer Summit 2023, Estoril, Portugal, 20-22/04/2023) [Poster]
Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C., Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area, «NUTRIENTS», 2022, 14, Article number: 1652 , pp. 1652 - 1663 [Scientific article]Open Access
Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri, Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2022, 9, pp. 1263 - 1278 [Scientific article]Open Access
Gramantieri, Laura; Fornari, Francesca, MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?, «ONCOSCIENCE», 2022, 9, pp. 52 - 54 [Comment or similar]Open Access
Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere, MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma, «BIOMOLECULES», 2022, 12(7), pp. 1 - 19 [Scientific article]Open Access
Gramantieri, Laura; Leoni, Ilaria; Pollutri, Daniela; Galvani, Giuseppe; Giovannini, Catia; Suzzi, Fabrizia; Casadei-Gardini, Andrea; Callegari, Elisa; Vasuri, Francesco; Ravaioli, Matteo; Cescon, Matteo; Piscaglia, Fabio; Negrini, Massimo; Fornari, Francesca, MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to
sorafenib Treatment, in: Abstract Book - 62nd Annual Meeting of the Italian Cancer Society: The exciting path from preclinical research to clinical application, 2022(atti di: 62nd Annual Meeting of the Italian Cancer Society: The exciting path from preclinical research to clinical application, Venezia, 16-18/11/2022) [Poster]
Fornari Francesca; Gramantieri Laura, Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma, in: MicroRNA in Human Malignancy, Amsterdam, Elsevier, 2022, pp. 301 - 315 [Chapter or essay]
Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L, Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2021, 8, pp. 741 - 757 [Scientific article]Open Access
Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F., Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers, «CANCERS», 2021, 13, Article number: 4550 , pp. 1 - 22 [Scientific article]Open Access
Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F, MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2021, 8, pp. 369 - 385 [Scientific article]Open Access
Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L., Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas, «CELLS», 2021, 10, Article number: 521 , pp. 1 - 20 [Scientific article]Open Access
Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M, Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 4485 - 4493 [Scientific article]Open Access
Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; Perrucci A.; Astolfi A.; Piscaglia F.; Gramantieri L., Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma, «CANCERS», 2020, 12, Article number: 2674 , pp. 1 - 17 [Scientific article]Open Access
Gramantieri L.; Pollutri D.; Gagliardi M.; Giovannini C.; Quarta S.; Ferracin M.; Casadei-Gardini A.; Callegari E.; De Carolis S.; Marinelli S.; Benevento F.; Vasuri F.; Ravaioli M.; Cescon M.; Piscaglia F.; Negrini M.; Bolondi L.; Fornari F., MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma, «CANCER RESEARCH», 2020, 80, pp. 1720 - 1734 [Scientific article]Open Access
